GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,309 Cr | ₹1,177 Cr | ₹909 Cr | ₹804 Cr | ₹762 Cr |
What is the latest Operating Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹1,309 Cr |
| Mar2025 | ₹1,177 Cr |
| Mar2024 | ₹909 Cr |
| Mar2023 | ₹804 Cr |
| Mar2022 | ₹762 Cr |
How is Operating Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,309 Cr | 11.20 | |
| Mar2025 | ₹1,177 Cr | 29.57 | |
| Mar2024 | ₹909 Cr | 12.98 | |
| Mar2023 | ₹804 Cr | 5.57 | |
| Mar2022 | ₹762 Cr | - | |
Compare Operating Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,902.2 Cr | 0.7% | -7.4% | -2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 0.7% |
-7.4% |
-2.6% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses